1,10-phenanthroline has been researched along with Cancer of Head in 1 studies
1,10-phenanthroline: RN given refers to parent cpd; inhibits Zn-dependent metalloproteinases
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, D | 1 |
| Peng, S | 1 |
| Amin, AR | 1 |
| Rahman, MA | 1 |
| Nannapaneni, S | 1 |
| Liu, Y | 1 |
| Shin, DM | 1 |
| Saba, NF | 1 |
| Eichler, JF | 1 |
| Chen, ZG | 1 |
1 other study available for 1,10-phenanthroline and Cancer of Head
| Article | Year |
|---|---|
Antitumor Activity of 2,9-Di-Sec-Butyl-1,10-Phenanthroline.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cisplatin; Drug | 2016 |